Post Approval Study of the remedē System

This Post Approval Study is a multi-center, prospective, single arm cohort study to evaluate
the long-term safety, long-term effectiveness, and survival rate in subjects implanted with
the remedē System from the remedē System Pivotal Trial. Only subjects who were implanted and
actively being followed as part of the remedē System Pivotal Trial are eligible. An
individual subject's participation is expected to continue to five years post remedē System
implant.

Inclusion Criteria:

- Subjects who were previously implanted with the remedē System and participated in the
remedē System Pivotal Trial

- In the investigator's opinion, willing and able to comply with all study requirements

- Signed Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved
informed consent (including Health Insurance Portability and Accountability Act
[HIPAA] authorization in the US)

Exclusion Criteria:

- There are no criteria by which a subject would be excluded